Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.verified

NWPHF

Price:

$20

Market Cap:

$272.32M

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing treatments for disorders affecting the central and peripheral nervous systems, as well as pain conditions. Operating in both Italy and the United States, the company's portfolio includes Xadago (safinamide), an approved therapy for Parkinson's disease, which is also under investigation for levodopa-induced dyskinesia. Additionally, Newron is developing Evenamide for schizophrenia and its treatment-resistant form, and Ralfinamide for specific orphan indications in neuropathic pain. Established in 1999, Newron Pharmaceuticals S.p.A. maintains its headquarters i...[Read more]

Industry

Biotechnology

IPO Date

2017-08-30

Stock Exchange

OTC

Ticker

NWPHF

The PE Ratio as of June 2026 (TTM) for Newron Pharmaceuticals S.p.A. (NWPHF) is -26.32

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current PE Ratio is -26.32. This represents a change of -78.92% compared to the average of -124.87 of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWPHF) Historical PE Ratio (quarterly & annually)

How has NWPHF PE Ratio performed in the past?

The mean historical PE Ratio of Newron Pharmaceuticals S.p.A. over the last ten years is -9.84. The current -26.32 PE Ratio has changed 26.65% with respect to the historical average. Over the past ten years (40 quarters), NWPHF's PE Ratio was at its highest in in the June 2017 quarter at 49.13. The PE Ratio was at its lowest in in the June 2025 quarter at -487.07.

Quarterly (TTM)
Annual

Average

-9.84

Median

-5.51

Minimum

-38.37

Maximum

11.15

Newron Pharmaceuticals S.p.A. (NWPHF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 267.08%

Maximum Annual PE Ratio = 11.15

Minimum Annual Increase = -443.99%

Minimum Annual PE Ratio = -38.37

Quarterly (TTM)
Annual
YearPE RatioChange
2025-38.37-443.99%
202411.15-290.30%
2023-5.86267.08%
2022-1.60-14.57%
2021-1.8710.63%
2020-1.69-67.29%
2019-5.16-18.51%
2018-6.34-79.26%
2017-30.5668.78%
2016-18.1128.11%

Newron Pharmaceuticals S.p.A. (NWPHF) Average PE Ratio

How has NWPHF PE Ratio performed in the past?

The current PE Ratio of Newron Pharmaceuticals S.p.A. (NWPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-11.03

5-year avg

-7.31

10-year avg

-9.84

Newron Pharmaceuticals S.p.A. (NWPHF) PE Ratio vs. Peers

How is NWPHF’s PE Ratio compared to its peers?

Newron Pharmaceuticals S.p.A.’s PE Ratio is less than Faron Pharmaceuticals Oy (-7.25), less than AnGes, Inc. (-3.67), greater than Hamilton Thorne Ltd. (-389.34), greater than Opsens Inc. (-26.89), less than Recce Pharmaceuticals Ltd (-4.83), less than Adocia S.A. (-5.06), less than Dialogue Health Technologies Inc. (-13.88), less than NIOX Group Plc (35.05), less than Planet 13 Holdings Inc. (-0.60), less than Guerbet S.A. (-1.16),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Newron Pharmaceuticals S.p.A.'s PE Ratio?

How is the PE Ratio calculated for Newron Pharmaceuticals S.p.A. (NWPHF)?

What is the highest PE Ratio for Newron Pharmaceuticals S.p.A. (NWPHF)?

What is the 3-year average PE Ratio for Newron Pharmaceuticals S.p.A. (NWPHF)?

What is the 5-year average PE Ratio for Newron Pharmaceuticals S.p.A. (NWPHF)?

How does the current PE Ratio for Newron Pharmaceuticals S.p.A. (NWPHF) compare to its historical average?